Cash flow Calbee, Inc. Börse Stuttgart

Stocks

9CB

JP3220580009

Food Processing

Delayed Börse Stuttgart 14:16:48 2026-08-27 EDT			5-day change	1st Jan Change
16.30 ^EUR	0.00%		+0.62%	+1.88%

07-29	Calbee, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2027	CI
07-29	Calbee, Inc. Provides Year End Dividend Guidance for the Fiscal Year Ending March 31, 2027	CI

ce.QXaOaXT7U9TvNHxkAJWG1tsT_b6ONPdS03tJGJXiKto.CwPUKBuQCaG7YhEyaczW4eJYjcnRY7oRmx8iKMShGIIVOMtQLMocsNZZCw

Published financial data: CALBEE, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022 (JPY)	2023 (JPY)	2024 (JPY)	2025 (JPY)	2026 (JPY)
Revenues	245B	279B	303B	323B	340B
Total Revenues	245B	279B	303B	323B	340B
Cost of Goods Sold, Total	161B	189B	201B	213B	229B
Gross Profit	83.95B	90.2B	102B	110B	111B
Selling General & Admin Expenses, Total	58.79B	67.87B	74.65B	80.76B	84.56B
Provision for Bad Debts	25M	99M	-	57M	70M
Depreciation & Amortization - (IS)	99M	112M	146M	72M	58M
Other Operating Expenses, Total	58.92B	68.08B	74.8B	80.88B	84.69B
Operating Income	25.04B	22.12B	27.16B	28.99B	26.12B
Interest Expense, Total	-99M	-162M	-250M	-357M	-388M
Interest And Investment Income	123M	179M	488M	1.05B	690M
Net Interest Expenses	24M	17M	238M	695M	302M
Income (Loss) On Equity Invest.	19M	24M	17M	16M	23M
Currency Exchange Gains (Loss)	1.71B	1.12B	3.51B	-203M	387M
Other Non Operating Income (Expenses)	146M	172M	232M	342M	261M
EBT, Excl. Unusual Items	26.94B	23.46B	31.16B	29.84B	27.09B
Gain (Loss) On Sale Of Investments	-7M	54M	163M	25M	93M
Gain (Loss) On Sale Of Assets	-17M	-21M	-353M	-78M	-73M
Asset Writedown	-407M	-1.1B	-749M	-454M	-730M
Legal Settlements	-	-	-	-	-135M
Other Unusual Items	240M	249M	-12M	60M	-57M
EBT, Incl. Unusual Items	26.75B	22.64B	30.2B	29.4B	26.19B
Income Tax Expense	8.47B	7.67B	9.74B	7.89B	8.61B
Earnings From Continuing Operations	18.28B	14.97B	20.46B	21.5B	17.57B
Net Income to Company	18.28B	14.97B	20.46B	21.5B	17.57B
Minority Interest	-224M	-201M	-579M	-631M	-245M
Net Income - (IS)	18.05B	14.77B	19.89B	20.87B	17.33B
Net Income to Common Incl Extra Items	18.05B	14.77B	19.89B	20.87B	17.33B
Net Income to Common Excl. Extra Items	18.05B	14.77B	19.89B	20.87B	17.33B
Per Share Items
Net EPS - Basic	136.25	115.16	159.22	167.1	139.97
Basic EPS - Continuing Operations	136.25	115.16	159.22	167.1	139.97
Basic Weighted Average Shares Outstanding	133M	128M	125M	125M	124M
Net EPS - Diluted	136.25	115.16	159.22	167.1	139.97
Diluted EPS - Continuing Operations	136.25	115.16	159.22	167.1	139.97
Diluted Weighted Average Shares Outstanding	133M	128M	125M	125M	124M
Normalized Basic EPS	125.37	112.73	151.26	144.27	134.78
Normalized Diluted EPS	125.37	112.73	151.26	144.27	134.78
Dividend Per Share	52	52	56	58	66
Payout Ratio	37.07	45.51	32.71	33.56	41.88
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	36.04B	34.15B	39.83B	43.29B	43.21B
EBITA	26.86B	24.1B	29.24B	31.15B	28.4B
EBIT	25.04B	22.12B	27.16B	28.99B	26.12B
Effective Tax Rate - (Ratio)	31.67	33.86	32.24	26.85	32.89
Normalized Net Income	16.61B	14.46B	18.89B	18.02B	16.69B
Non-Cash Pension Expense	-112M	13M	89M	351M	492M
Supplemental Operating Expense Items
Advertising Expense	6.51B	8.96B	10.78B	12.58B	12.51B
Selling and Marketing Expenses	21.78B	25.3B	27.82B	30.32B	31.71B
Research And Development Expense From Footnotes	3.32B	3.68B	3.91B	4.23B	4.51B

Fiscal Period: March	2022 (JPY)	2023 (JPY)	2024 (JPY)	2025 (JPY)	2026 (JPY)
Assets
Cash And Equivalents	35B	32.17B	44.3B	56.76B	51.55B
Short Term Investments	24B	-	-	-	-
Total Cash And Short Term Investments	59B	32.17B	44.3B	56.76B	51.55B
Accounts Receivable, Total	32.58B	37.01B	54.04B	41.5B	43.66B
Total Receivables	32.58B	37.01B	54.04B	41.5B	43.66B
Inventory	18B	23.35B	22.21B	25.14B	29.09B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	5.59B	6.44B	7.31B	10.45B	7.39B
Total Current Assets	115B	98.97B	128B	134B	132B
Net Property Plant And Equipment	82.98B	102B	124B	146B	155B
Long-term Investments	7.09B	7.6B	9.97B	10.28B	11.23B
Goodwill	23.55B	23.22B	22.65B	20.55B	20.99B
Other Intangibles, Total	2.53B	2.71B	2.62B	3.66B	3.76B
Loans Receivable Long-Term	100M	100M	-	-	-
Deferred Tax Assets Long-Term	5.18B	4.96B	5.41B	5.06B	4.48B
Other Long-Term Assets, Total	1M	2M	1M	3M	2M
Total Assets	237B	239B	292B	319B	328B
Liabilities
Accounts Payable, Total	11.85B	13.55B	12.54B	13.36B	14.74B
Accrued Expenses, Total	4.72B	5.5B	6.72B	22.73B	19.71B
Short-term Borrowings	1.45B	1.29B	1.43B	883M	1.77B
Current Portion of Long-Term Debt	-	-	-	-	10B
Current Portion of Leases	160M	156M	169M	203M	399M
Current Income Taxes Payable	12.47B	12.14B	18.48B	17.42B	15.1B
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	11.61B	13.02B	15.14B	1.12B	3.23B
Total Current Liabilities	42.26B	45.66B	54.48B	55.7B	64.94B
Long-Term Debt	-	-	25B	35B	25B
Long-Term Leases	375M	403M	433M	468M	872M
Pension & Other Post Retirement Benefits	8.38B	7.85B	8.12B	8.95B	8.81B
Deferred Tax Liability Non Current	906M	1.29B	1.85B	1.9B	2.42B
Other Non Current Liabilities	1.22B	1.21B	1.19B	2.08B	3.79B
Total Liabilities	53.14B	56.41B	91.07B	104B	106B
Common Stock, Total	12.05B	12.05B	12.05B	12.05B	12.05B
Additional Paid In Capital	3.23B	3.24B	2.51B	2.51B	2.51B
Retained Earnings	170B	178B	192B	206B	216B
Treasury Stock	-12.96B	-24.89B	-24.97B	-24.78B	-34.67B
Comprehensive Income and Other	2.78B	5.38B	10.46B	9.83B	15.07B
Total Common Equity	175B	174B	192B	205B	211B
Minority Interest	8.08B	8.57B	9.34B	9.89B	11.17B
Total Equity	183B	183B	201B	215B	222B
Total Liabilities And Equity	237B	239B	292B	319B	328B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	129M	125M	125M	125M	122M
ECS Total Common Shares Outstanding	129M	125M	125M	125M	122M
Book Value / Share	1.36K	1.39K	1.54K	1.64K	1.73K
Tangible Book Value	149B	148B	166B	181B	186B
Tangible Book Value Per Share	1.16K	1.19K	1.33K	1.45K	1.53K
Total Debt	1.98B	1.85B	27.04B	36.55B	38.04B
Net Debt	-57.02B	-30.32B	-17.26B	-20.2B	-13.51B
Debt Equivalent of Unfunded Proj. Benefit Obligation	5.15B	4.09B	3.51B	3.65B	2.49B
Minority Interest, Total (Incl. Fin. Div)	8.08B	8.57B	9.34B	9.89B	11.17B
Inventories - Raw Materials, Total	9.06B	12.58B	12.37B	13.2B	15.87B
Inventories - Work In Process, Total	1.4B	1.9B	2.25B	2.7B	2.8B
Inventories - Finished Goods, Total	7.54B	8.87B	7.58B	9.23B	10.42B
Inventories - Others	1M	-	1M	-	1M
Full Time Employees	4.4K	4.84K	4.94K	5.14K	6.97K
Accumulated Allowance for Doubtful Accounts (Supple)	6M	110M	78M	122M	174M

Fiscal Period: March	2022 (JPY)	2023 (JPY)	2024 (JPY)	2025 (JPY)	2026 (JPY)
Net Income	26.75B	22.64B	30.2B	29.4B	26.19B
Depreciation & Amortization - CF	9.19B	10.05B	10.59B	12.14B	14.81B
Amortization of Goodwill and Intangible Assets - (CF)	1.82B	1.98B	2.08B	2.15B	2.28B
Depreciation & Amortization, Total	11.01B	12.03B	12.68B	14.3B	17.09B
(Gain) Loss From Sale Of Asset	424M	1.12B	977M	455M	737M
(Gain) Loss on Sale of Investments - (CF)	16M	-54M	-75M	-25M	-93M
(Income) Loss On Equity Investments - (CF)	-19M	-23M	-17M	-16M	-23M
Other Operating Activities, Total	-8.95B	-8.18B	-6.72B	-10.04B	-8.23B
Change In Accounts Receivable	-1.22B	-3.99B	-15.77B	12.18B	-659M
Change In Inventories	-2.78B	-4.92B	1.82B	-3.1B	-3.12B
Change In Accounts Payable	888M	860M	1.83B	475M	-183M
Change in Other Net Operating Assets	-3.79B	-178M	-582M	-4.53B	3.88B
Cash from Operations	22.33B	19.31B	24.35B	39.1B	35.6B
Capital Expenditure	-12.49B	-25.75B	-30.59B	-28.11B	-23.4B
Sale of Property, Plant, and Equipment	15M	12M	140M	10M	22M
Cash Acquisitions	-	-1.56B	-	-	-2.19B
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-1.02B	-966M	-595M	-1.41B	-1.58B
Investment in Marketable and Equity Securities, Total	16.68B	7.51B	-4.34B	863M	799M
Net (Increase) Decrease in Loans Originated / Sold - Investing	80M	78M	-	100M	-
Other Investing Activities, Total	381M	341M	79M	-64M	131M
Cash from Investing	3.64B	-20.33B	-35.31B	-28.6B	-26.21B
Short Term Debt Issued, Total	-	-	41M	-	819M
Long-Term Debt Issued, Total	-	-	25B	10B	-
Total Debt Issued	-	-	25.04B	10B	819M
Short Term Debt Repaid, Total	-1.3B	-235M	-	-504M	-
Long-Term Debt Repaid, Total	-3.46B	-535M	-	-	-
Total Debt Repaid	-4.76B	-770M	-	-504M	-
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-12B	-12B	-240M	-	-10B
Common Dividends Paid	-6.69B	-6.72B	-6.5B	-7B	-7.26B
Common & Preferred Stock Dividends Paid	-6.69B	-6.72B	-6.5B	-7B	-7.26B
Other Financing Activities, Total	-1.71B	-512M	-1.45B	50M	-565M
Cash from Financing	-25.17B	-20B	16.85B	2.54B	-17B
Foreign Exchange Rate Adjustments	1.58B	1.64B	1.53B	263M	2.18B
Miscellaneous Cash Flow Adjustments	1M	-	-	-	-
Net Change in Cash	2.39B	-19.38B	7.43B	13.3B	-5.44B
Supplemental Items
Cash Interest Paid	106M	169M	210M	335M	406M
Cash Income Tax Paid (Refund)	8.93B	8.18B	6.75B	10.06B	8.22B
Levered Free Cash Flow	8B	-8.04B	-9.79B	10.9B	3.3B
Unlevered Free Cash Flow	8.06B	-7.94B	-9.64B	11.13B	3.55B
Change In Net Working Capital	5.08B	7.07B	8.1B	-8.22B	4.9B
Net Debt Issued / Repaid	-4.76B	-770M	25.04B	9.5B	819M

Fiscal Period: March	2022 (JPY)	2023 (JPY)	2024 (JPY)	2025 (JPY)	2026 (JPY)
Profitability
Return on Assets	6.58	5.81	6.39	5.93	5.05
Return on Total Capital	8.35	7.47	8.23	7.55	6.38
Return On Equity %	9.98	8.18	10.67	10.34	8.05
Return on Common Equity	10.29	8.45	10.87	10.52	8.34
Margin Analysis
Gross Profit Margin %	34.21	32.29	33.65	34.06	32.58
SG&A Margin	23.96	24.3	24.64	25.04	24.86
EBITDA Margin %	14.69	12.23	13.15	13.42	12.7
EBITA Margin %	10.94	8.63	9.65	9.66	8.35
EBIT Margin %	10.2	7.92	8.96	8.99	7.68
Income From Continuing Operations Margin %	7.45	5.36	6.75	6.67	5.17
Net Income Margin %	7.36	5.29	6.56	6.47	5.09
Net Avail. For Common Margin %	7.36	5.29	6.56	6.47	5.09
Normalized Net Income Margin	6.77	5.18	6.23	5.59	4.91
Levered Free Cash Flow Margin	3.26	-2.88	-3.23	3.38	0.97
Unlevered Free Cash Flow Margin	3.28	-2.84	-3.18	3.45	1.04
Asset Turnover
Asset Turnover	1.03	1.17	1.14	1.06	1.05
Fixed Assets Turnover	3.06	3.03	2.69	2.39	2.26
Receivables Turnover (Average Receivables)	7.79	8.03	6.66	6.75	7.99
Inventory Turnover (Average Inventory)	9.88	9.15	8.83	8.98	8.46
Short Term Liquidity
Current Ratio	2.73	2.17	2.35	2.4	2.03
Quick Ratio	2.17	1.51	1.81	1.76	1.47
Operating Cash Flow to Current Liabilities	0.53	0.42	0.45	0.7	0.55
Days Sales Outstanding (Average Receivables)	46.86	45.47	54.99	54.05	45.69
Days Outstanding Inventory (Average Inventory)	36.95	39.91	41.47	40.62	43.15
Average Days Payable Outstanding	24.38	23.84	23.88	21.92	21.98
Cash Conversion Cycle (Average Days)	59.44	61.53	72.57	72.76	66.86
Long Term Solvency
Total Debt/Equity	1.08	1.01	13.44	17	17.15
Total Debt / Total Capital	1.07	1	11.85	14.53	14.64
LT Debt/Equity	0.2	0.22	12.65	16.49	11.67
Long-Term Debt / Total Capital	0.2	0.22	11.15	14.1	9.96
Total Liabilities / Total Assets	22.46	23.59	31.17	32.62	32.31
EBIT / Interest Expense	252.9	136.55	108.64	81.22	67.31
EBITDA / Interest Expense	364.09	210.78	159.34	121.26	111.37
(EBITDA - Capex) / Interest Expense	237.92	51.83	36.97	42.53	51.07
Total Debt / EBITDA	0.05	0.05	0.68	0.84	0.88
Net Debt / EBITDA	-1.58	-0.89	-0.43	-0.47	-0.31
Total Debt / (EBITDA - Capex)	0.08	0.22	2.92	2.41	1.92
Net Debt / (EBITDA - Capex)	-2.42	-3.61	-1.87	-1.33	-0.68
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-8	13.81	8.49	6.45	5.45
Gross Profit, 1 Yr. Growth %	-28.74	7.44	13.04	7.77	0.84
EBITDA, 1 Yr. Growth %	-4.46	-5.27	16.65	8.68	-0.18
EBITA, 1 Yr. Growth %	-6.35	-10.26	21.33	6.52	-8.82
EBIT, 1 Yr. Growth %	-7.01	-11.65	22.77	6.76	-9.92
Earnings From Cont. Operations, 1 Yr. Growth %	1.17	-18.08	36.68	5.08	-18.28
Net Income, 1 Yr. Growth %	2.1	-18.17	34.62	4.97	-16.98
Normalized Net Income, 1 Yr. Growth %	-1.22	-12.95	30.65	-4.61	-7.41
Diluted EPS Before Extra, 1 Yr. Growth %	2.98	-15.48	38.26	4.95	-16.23
Accounts Receivable, 1 Yr. Growth %	7	13.61	46.01	-23.21	5.21
Inventory, 1 Yr. Growth %	22.51	29.73	-4.9	13.18	15.74
Net Property, Plant and Equip., 1 Yr. Growth %	7.37	22.36	21.79	17.89	6.64
Total Assets, 1 Yr. Growth %	-1	1.06	22.19	9.25	2.64
Tangible Book Value, 1 Yr. Growth %	0.29	-0.75	12.35	8.71	2.7
Common Equity, 1 Yr. Growth %	0.01	-0.72	10.13	7	2.64
Cash From Operations, 1 Yr. Growth %	-26.68	-13.51	26.1	60.57	-8.96
Capital Expenditures, 1 Yr. Growth %	16.57	106.15	18.8	-8.12	-16.76
Levered Free Cash Flow, 1 Yr. Growth %	-50.93	-200.47	21.84	-211.35	-69.69
Unlevered Free Cash Flow, 1 Yr. Growth %	-50.74	-198.44	21.43	-215.47	-68.12
Dividend Per Share, 1 Yr. Growth %	4	0	7.69	3.57	13.79
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-2.08	2.33	11.12	7.46	5.95
Gross Profit, 2 Yr. CAGR %	-14.59	-12.5	10.2	10.37	4.25
EBITDA, 2 Yr. CAGR %	-0.9	-4.87	5.12	12.59	4.15
EBITA, 2 Yr. CAGR %	-2.51	-8.33	4.34	13.68	-1.45
EBIT, 2 Yr. CAGR %	-4.66	-9.36	4.15	14.49	-1.94
Earnings From Cont. Operations, 2 Yr. CAGR %	3.05	-8.96	5.82	19.84	-7.33
Net Income, 2 Yr. CAGR %	1.45	-8.6	4.95	18.87	-6.65
Normalized Net Income, 2 Yr. CAGR %	-2.48	-7.27	6.64	11.63	-6.02
Diluted EPS Before Extra, 2 Yr. CAGR %	1.9	-6.7	8.1	20.46	-6.24
Accounts Receivable, 2 Yr. CAGR %	4.71	10.26	28.8	5.89	-10.12
Inventory, 2 Yr. CAGR %	26.75	26.06	11.07	3.75	14.45
Net Property, Plant and Equip., 2 Yr. CAGR %	7.56	14.62	22.07	19.83	12.13
Total Assets, 2 Yr. CAGR %	4.91	0.02	11.12	15.54	5.89
Tangible Book Value, 2 Yr. CAGR %	-0.3	-0.23	5.6	10.51	5.66
Common Equity, 2 Yr. CAGR %	3.65	-0.36	4.56	8.56	4.8
Cash From Operations, 2 Yr. CAGR %	-25.7	-20.37	4.43	42.3	20.91
Capital Expenditures, 2 Yr. CAGR %	22	55.02	56.49	4.47	-12.55
Levered Free Cash Flow, 2 Yr. CAGR %	-48.36	-29.79	10.64	16.48	-41.91
Unlevered Free Cash Flow, 2 Yr. CAGR %	-48.21	-30.37	9.33	18.41	-39.33
Dividend Per Share, 2 Yr. CAGR %	1.98	1.98	3.77	5.61	8.56
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-0.44	2.96	4.34	9.54	6.79
Gross Profit, 3 Yr. CAGR %	-8.92	-7.8	-4.7	9.38	7.1
EBITDA, 3 Yr. CAGR %	0.36	-2.38	1.83	6.3	8.16
EBITA, 3 Yr. CAGR %	-0.94	-5.16	0.65	5.06	5.62
EBIT, 3 Yr. CAGR %	-2.33	-7.05	0.29	5.01	5.69
Earnings From Cont. Operations, 3 Yr. CAGR %	-1.93	-4.54	4.25	5.57	5.48
Net Income, 3 Yr. CAGR %	-2.42	-5.56	3.99	4.96	5.47
Normalized Net Income, 3 Yr. CAGR %	-1.22	-6.1	3.96	2.75	4.89
Diluted EPS Before Extra, 3 Yr. CAGR %	-2.13	-4.26	6.37	7.04	6.72
Accounts Receivable, 3 Yr. CAGR %	-6.4	7.6	21.08	8.4	5.66
Inventory, 3 Yr. CAGR %	16.76	27.73	14.76	11.77	7.6
Net Property, Plant and Equip., 3 Yr. CAGR %	4.58	12.29	16.96	20.66	15.26
Total Assets, 3 Yr. CAGR %	5.28	3.61	6.93	10.49	11.07
Tangible Book Value, 3 Yr. CAGR %	0.7	-0.45	3.8	6.62	7.84
Common Equity, 3 Yr. CAGR %	4.44	2.17	3.02	5.37	6.55
Cash From Operations, 3 Yr. CAGR %	-6.85	-21.84	-7.18	20.54	22.61
Capital Expenditures, 3 Yr. CAGR %	9.98	45.31	41.86	31.04	-3.15
Levered Free Cash Flow, 3 Yr. CAGR %	-24.53	-35.54	-15.63	10.88	-25.64
Unlevered Free Cash Flow, 3 Yr. CAGR %	-24.4	-35.85	-16.19	11.34	-23.54
Dividend Per Share, 3 Yr. CAGR %	2.7	1.32	3.85	3.71	8.27
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.56	2.11	4.03	4.74	4.98
Gross Profit, 5 Yr. CAGR %	-5.53	-3.7	-1.71	-0.92	-1.22
EBITDA, 5 Yr. CAGR %	-0.3	-0.62	2.24	3.36	2.75
EBITA, 5 Yr. CAGR %	-1.72	-2.53	1.14	1.97	-0.2
EBIT, 5 Yr. CAGR %	-2.68	-3.76	0.21	1.03	-0.61
Earnings From Cont. Operations, 5 Yr. CAGR %	-0.72	-2.59	1.1	4.55	-0.55
Net Income, 5 Yr. CAGR %	-0.6	-3.14	0.47	3.54	-0.4
Normalized Net Income, 5 Yr. CAGR %	-1.09	-2.74	1.85	0.63	-0.16
Diluted EPS Before Extra, 5 Yr. CAGR %	-0.41	-2.34	1.84	4.95	1.13
Accounts Receivable, 5 Yr. CAGR %	2.66	-2.37	6.35	6.91	7.48
Inventory, 5 Yr. CAGR %	12.71	16.79	14.45	17.54	14.64
Net Property, Plant and Equip., 5 Yr. CAGR %	3.22	6.79	11.25	15.24	15
Total Assets, 5 Yr. CAGR %	5.39	4.47	7.58	8.23	6.51
Tangible Book Value, 5 Yr. CAGR %	3.84	1.73	2.63	3.8	4.54
Common Equity, 5 Yr. CAGR %	6.48	4.55	4.49	4.68	3.73
Cash From Operations, 5 Yr. CAGR %	-2.97	15.59	-2.49	-0.68	3.17
Capital Expenditures, 5 Yr. CAGR %	5.91	19.46	26.64	27.35	16.9
Levered Free Cash Flow, 5 Yr. CAGR %	-8.91	21.81	-12.05	-18.33	-27.33
Unlevered Free Cash Flow, 5 Yr. CAGR %	-8.8	21.91	-12.38	-18.03	-26.35
Dividend Per Share, 5 Yr. CAGR %	4.36	4.36	3.13	3.01	5.71